Jasper Therapeutics Inc (NAS:JSPR)
$ 22.54 0.38 (1.72%) Market Cap: 339.42 Mil Enterprise Value: 218.22 Mil PE Ratio: 0 PB Ratio: 3.00 GF Score: 23/100

Jasper Therapeutics Inc Extraordinary Shareholders Meeting Transcript

Dec 15, 2023 / 06:00PM GMT
Release Date Price: $4.84 (-1.06%)
Ron Martell Jasper Therapeutics
Inc. - President, CEO, and Director

Good morning, ladies and gentlemen. Welcome to the 2023 Special Meeting of Stockholders of Jasper Therapeutics, Inc. I'm Ron Martell, the company's Chief Executive Officer and President. At this time, I'll call the meeting to order. I am pleased to conduct our meeting virtually.

The company's Board of Directors has appointed me to act as Chairman of this meeting. Herb Cross, the company's Chief Financial Officer will act as Secretary of this meeting. The Board of Directors has appointed Henry Farrell of Continental Stock Transfer & Trust Company to act as Inspector of Election for this meeting. Mr. Farrell has previously taken his oath of Inspector of Election. We will file the executed oath with the recordings of this meeting.

Many stockholders have already submitted their proxies. All proxies will be voted as marked by the stockholders signing them. If you have voted by proxy, you do not need to take any further action. If you wish to vote during the meeting, please log into the web portal as a stockholder by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot